Radar > 378635

Splice Bio partners with Spark Therapeutics to develop a therapy for retinal disease

Splice Bio se alía con Spark Therapeutics para desarrollar una terapia contra una enfermedad de la retina

Intel ID : 378635

Target


Intel ID 378635
Value ND
Native Currency Euro (EUR)
Financial Data - Splice Bio
(31 Dec 2023)
Revenue: EUR 5,81m
People: 24
Date
Country
Geography
Subsector (Old TTR Sectors)
Primary Subsector (TTRSC)
30.01.99 Other Biotechnology & Pharmaceuticals (Primary)
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

30.01.02 Molecular Science, Genetics & Gene Therapy (Primary)
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

Secondary Subsectors (TTRSC)
15.06.01 Colleges & Universities
15 Consumer Products & Services / 15.06 Education & Training Services

Type
Intel Grade
Source
Tags

Target

Name
verified
Subsector (Old TTR Sectors)
Technology and Telecoms / Biotechnology (Primary)
Services and Distribution / Healthcare, Hygiene, Medical Aesthetics and Cosmetics
Primary Sector (TTRSC)
30.01.02 Molecular Science, Genetics & Gene Therapy
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

Country
Website
Description

Target

Name
verified
Subsector (Old TTR Sectors)
Technology and Telecoms / Biotechnology (Primary)
Primary Sector (TTRSC)
30.01.99 Other Biotechnology & Pharmaceuticals
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

Secondary Sectors (TTRSC)
15.06.01 Colleges & Universities
15 Consumer Products & Services / 15.06 Education & Training Services

Country
Website
Description

Legend:

verified Verified: Confirmed as a party to an active or possible transaction.

potential Potential: Unconfirmed as a party to an active or possible transaction.

retained Retained: Confirmed as “Retained” with a general or specific mandate.

prospect Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.

Transactional data is continuously updated by the research team and therefore is subject to change.